Malog, Nurisa .

HRN: 27-93-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
CEFTRIAXONE 1G (VIAL)
10/11/2025
10/18/2025
IVT
2g
Q24
Postpartum Cardiomegaly, Postpartum Eclampsiap
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: